Latest Information Update: 22 Feb 2016
At a glance
- Originator TCM Biotech International
- Mechanism of Action Immunoglobulin modulators
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
On Fast track
Fast track status is assigned by the US FDA so therapies with the potential to address unmet needs can move faster through development.
- New Molecular Entity No
Highest Development Phases
- Preclinical Hepatic fibrosis
Most Recent Events
- 22 Feb 2016 Preclinical trials in Hepatic fibrosis in Taiwan (unspecified route)